Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005017235 | SCV005638478 | uncertain significance | Familial juvenile hyperuricemic nephropathy type 1 | 2024-06-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004739051 | SCV005341112 | uncertain significance | UMOD-related disorder | 2024-08-26 | no assertion criteria provided | clinical testing | The UMOD c.1271C>T variant is predicted to result in the amino acid substitution p.Ala424Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |